Technology | September 05, 2007

FDA Clears St. Jude’s ACross Transseptal Access System


St. Jude Medical Inc. announced that the FDA cleared the ACross Transseptal Access System, a device designed to improve control and simplify the procedure physicians use to access the left atrium during complex cardiac procedures such as atrial fibrillation ablation.
The device, engineered to enable access to the left atrium of the heart, consolidates the sheath, dilator and needle into a single interlocking handle for greater control over the system’s components and more intuitive positioning within the heart. The device’s handle allows the components to fit precisely together, ensuring that the puncture needle is not deployed until the physician is confident in its location, and that it is only advanced a predetermined distance. Also, the ergonomic design incorporates a directional fin, or ridge, on the handle, designed for the physician to intuitively know the orientation of the needle and sheath tip within the heart.


Additional Content

News | Cardiovascular Surgery

May 4, 2026 — Johnson & Johnson recently announced new data from a novel U.S. pilot single-arm trial that evaluated the ...

Home May 05, 2026
Home
News | Cardiovascular Surgery

March 24, 2026 — iPerf, a company specializing in the development of medical devices for cardiopulmonary support, has ...

Home March 25, 2026
Home
News | Cardiovascular Surgery

Feb. 11, 2026 —The American Roentgen Ray Society (ARRS) has announced the following radiologists, as well as their ...

Home February 13, 2026
Home
News | Cardiovascular Surgery

Feb. 11, 2026 – Columbia HeartSource, an extension of Columbia University Irving Medical Center’s Department of Surgery ...

Home February 12, 2026
Home
News | Cardiovascular Surgery

Feb. 6, 2026 — Robert Wood Johnson University Hospital (RWJUH), in partnership with Rutgers Robert Wood Johnson Medical ...

Home February 06, 2026
Home
Subscribe Now